PostDoc position in Biological Sciences / Biochemistry: Mode of action of antimalarial benzylmenadiones at IBMC, Strasbourg, France
A renewable 1-year postdoctoral position is open at IBMC (Inserm/CNRS/University of Strasbourg) to investigate the mode of action of novel and promising antimalarial benzylmenadiones with potent curing and transmission blocking activities. This project is based on a combination of complementary strategies, notably genetics, activity-based protein profiling and proteomics in both yeast and Plasmodium parasites, to identify putative benzylmenadione targets. Candidate targets will be validated by genetic engineering in Plasmodium, and their role in parasite biology and in mediating benzylmenadione activity will be investigated.
Project leader:
The project will be supervised by Dr. Stephanie Blandin. It is part of a French/Swiss collaborative consortium working on novel antimalarial drugs and encompassing multiple disciplines: medicinal chemistry of redox-active antiparasitic compounds (Dr. Elisabeth Davioud-Charvet at ECPM, Strasbourg), mass spectrometry analysis & proteomics (Drs. Christine Schaeffer & Jean-Marc Strub at IPHC, Strasbourg), parasitology and drug screening (Profs. Pascal Maeser & Jennifer Keiser at Swiss TPH in Basel, Switzerland), yeast genetics (Dr. Brigitte Meunier at I2BC, Gif-sur-Yvette, France) and biology of mosquitoes and malarial parasites (Dr Stephanie Blandin at IBMC, Strasbourg).
Project:
The researcher will join the research unit Insect Models of Innate Immunity (M3i), located at the Institute of Molecular and Cellular Biology (IBMC) in Strasbourg, and more particularly the Inserm team 'Immune responses in mosquito vectors'. This group, led by Dr. Stephanie Blandin, is dedicated to the study of the resistance/susceptibility of mosquitoes to pathogens transmitted to humans (parasites and viruses), and to the development of novel strategies to limit disease transmission, including (but not limited to) novel drugs.
The postdoctoral researcher will start by evaluating a series of candidate target genes to decipher the mode of action of antimalarial benzylmenadiones in Plasmodium parasites. In parallel, he/she will look for additional candidates using an affinity-based protein profiling approach coupled with proteomics for which we have already reported a first proofof- concept (Cichocki B. et al., JACSAu 2021, 1(5):669-689. doi: 10.1021/jacsau.1c00025). The candidate should be ready to come up with new models, and to develop relevant assays to test them. Main activities: - Parasitology: Plasmodium falciparum culture (both asexual and gametocytes), parasite enrichment, transfection, assays to measure parasite sensitivity and resistance to drugs, establishment of new assays. - Molecular Biology: construction of plasmids for CRISPR/Cas9 and Selection-Linked Integration (SLI) to generate knockout, overexpression and allele replacement of putative target genes, validation of cassette insertion... - Affinity-Based Protein Profiling to identify new benzylmenadione targets in parasites - Reporting of results in electronic lab-book & lab meetings, attendance to conferences, writing manuscripts. - Supervision of students (recommended)
Activities and experience:
PhD degree required
We are looking for a highly motivated, and creative candidate with a strong background in parasitology (fundamental criteria). Additional expertise in drug discovery, molecular biology and/or proteomics would be appreciated. The ideal candidate will have a proven track record of scientific excellence, very good communication and writing skills as well as a strong commitment to experimental work. The candidate should be also able to perform independent research and will be encouraged to make use of the expertise and facilities of partners whenever necessary. Knowledge of the French language is not required. Thorough knowledge of English, both oral and written, is mandatory.
Application:
Application deadline : 27/01/2023
Application e-mail : bstevenin (at) unistra.fr
Emerging Leader Research Fellow, Oxford Brookes University, UK The Oxford Brookes University offers an opportunity to develop an independent research group in molecular parasitology/protistology through a...
PostDoc position : Gene regulation/ DNA low complexity regions-DNA binding proteins, Montpellier, France The post-doc project aims to investigate the role of Low Complexity Regions in regulation of gene expression in P....
Short-Term Scientific Missions (STSMs) within the OneHealthdrugs (CA21111) network 1st CALL for applications 2023 The 1st STSM Call of the Action CA2111 OneHealthdrugs is launched. Short Term Scientific Mission...
PostDoc position : Cross-talk between stress response and infection in dendritic cells at Institut Pasteur Lille, France We seek to hire a highly motivated candidate to work on the role of the Unfolded Protein...
[Publication] Les derniers travaux de Rania Najm, Hiba El Hajj, Maryse Lebrun & leurs collègues sont publiés dans PNAS. Les auteurs apportent des connaissances importantes sur les acteurs moléculaires de l'invasion des bradyzoïtes et...
Le LabEx ParaFrap vous souhaite plein de bonheur, de santé, de science et de succès pour 2023. Première actualité du réseau cette année : les webinaires ParaFrap reprennent en 2023, comme les années précédentes, tous les deuxième jeudi du...
PostDoc position in Biological Sciences / Biochemistry: Mode of action of antimalarial benzylmenadiones at IBMC, Strasbourg, France A renewable 1-year postdoctoral position is open at IBMC (Inserm/CNRS/University...
[Communiqué] Gerald Spaeth, chef de l'unité "Parasitologie moléculaire et signalisation" à L'institut pasteur Paris, a obtenu une subvention Synergy du Conseil européen de la recherche (ERC) pour le projet "DECOLeishRN -...
PostDoc position studying host-pathogen interactions at Institut Pasteur, Paris, France A postdoc position is available at the Institut Pasteur in the signalling and host-parasite interactions group, headed by Najma Rachidi, to investigate the...
[Communiqué] L'équipe du Dr Chetan Chitnis de l’Institut Pasteur, partenaire du LabEx ParaFrap, a étudié le stade sanguin du parasite Plasmodium falciparum, à l’origine de la forme la plus sévère et la plus mortelle du paludisme, et...
Actualités du LabEx
Autres actualités
Project Manager: Yoann MILLERIOUX
Contact
![]() |
@ParaFrap #ParaFrap |
© 2023. Tous droits réservés by MLCOM
Notre site LabEx ParaFrap utilise des cookies pour réaliser des statistiques de visites, partager des contenus sur les réseaux sociaux et améliorer votre expérience. En refusant les cookies, certains services seront amenés à ne pas fonctionner correctement. Nous conservons votre choix pendant 30 jours. Vous pouvez changer d'avis en cliquant sur le bouton 'Cookies' en bas à gauche de chaque page de notre site. En savoir plus
Ce site utilise des cookies pour assurer son bon fonctionnement et ne peuvent pas être désactivés de nos systèmes. Nous ne les utilisons pas à des fins publicitaires. Si ces cookies sont bloqués, certaines parties du site ne pourront pas fonctionner.
Ce site utilise des cookies de mesure et d’analyse d’audience, tels que Google Analytics et Google Ads, afin d’évaluer et d’améliorer notre site internet.
Ce site utilise des composants tiers, tels que NotAllowedScript647cc739199b4ReCAPTCHA, Google NotAllowedScript647cc73919507Maps, MailChimp ou Calameo, qui peuvent déposer des cookies sur votre machine. Si vous décider de bloquer un composant, le contenu ne s’affichera pas
Des plug-ins de réseaux sociaux et de vidéos, qui exploitent des cookies, sont présents sur ce site web. Ils permettent d’améliorer la convivialité et la promotion du site grâce à différentes interactions sociales.
Ce site web utilise un certain nombre de cookies pour gérer, par exemple, les sessions utilisateurs.